| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |